Abstract
Sustained attention deficits and high rates of smoking are often observed in patients with schizophrenia. This has led to the hypothesis that patients may smoke as an attempt to ameliorate cognitive deficits related to abnormal nicotinic structure and function. Continuous performance tasks (CPT) are often used to index sustained attention deficits in patients with schizophrenia, however, there are important differences between tasks that may impact performance in smokers and nonsmokers with schizophrenia differently. The Conners’ CPT (CCPT) has a high signal-to-noise ratio and is commonly used to assess impulsivity. The CPT-Identical Pairs (CPT-IP) has a low signal-to-noise ratio and is commonly used to assess negative symptoms in patients with schizophrenia. We sought to determine whether there were differences of sustained attention between patient smokers vs. nonsmokers, and if one CPT would provide a better separation of sustained attention between groups. Results revealed that both instruments detect more impaired sustained attention deficits in patient smokers compared to nonsmokers. Patient smokers performed significantly worse on the majority of the CPT-IP composite scores compared to the C-CPT composite scores. These results do not support the self-medication theory, as patient smokers performed worse than patient nonsmokers. Researchers studying sustained attention in schizophrenia may wish to consider the CPT-IP over the C-CPT, as well as control for smoking status.
Keywords: schizophrenia, nicotine, sustained attention, Continuous Performance Tasks
1. Introduction
People with schizophrenia (herein referred to as patients) have among the highest rates of smoking in the general population (D’Souza & Markou, 2012; Smith et al., 2006). This observation has led to the widely-discussed hypothesis that the high rates of smoking in patients indicate an attempt at self-medication to correct or transiently improve several of the cognitive deficits related to abnormal nicotinic structure and function (Segarra et al., 2011). This hypothesis would imply that there may be differences in the mechanisms responsible for cognitive functioning between patient smokers and nonsmokers that could provide information about this aspect of the heterogeneity of the schizophrenia syndrome. Demonstration of differences between these two groups, however, would depend upon a number of factors including the pre-smoking degree of impairment, down-regulation of receptors that mediate nicotine effects, and the type of cognitive functions involved.
Among the cognitive functions impaired in schizophrenia, sustained attention is one of the most robust and commonly replicated (Cornblatt et al., 1988; Hong et al., 2011, 2009), and is also closely related to the nicotinic acetylcholine receptors (nAChR) in the central nervous system (Dyer et al., 2008). To measure deficits in a particular type of cognitive operation such as sustained attention, it is obviously important to employ tasks that are optimally sensitive. However, few such evaluations have been performed in the schizophrenia-smoking literature. In this study, we compare two commonly used paradigms that have been used to index sustained attention in patients with psychotic disorders and other mental illness.
1.1. Measurement of Sustained Attention: Continuous Performance Tasks
Sustained attention is an instrumental assessment. The Conner's CPT (C-CPT; Conners, 2002) and CPT-Identical Pairs (CPT-IP; Cornblatt et al., 1988) are two sustained attention tasks that have commonly been used to examine nicotine or smoking effects. In the C-CPT, the participant must press the space bar key as quickly as possible when a target stimulus (any letter except “X”) is presented on the screen (a “hit”), and refrain from responding when the non-target stimulus (the letter “X”) is presented. The C-CPT has a high signal-to-noise ratio (d’); the target stimulus (signal) occurs 90% of the time, and a non-target stimulus (noise) occurs 10% of the time. Thus, the participant must inhibit the tendency to press a key when the non-target stimulus is displayed. This feature allows C-CPT to be efficacious for identifying and assessing impulsivity and is sensitive to errors of commission. The C-CPT has been found to be effective at distinguishing attention disorders in children and adults (Barkley et al., 1996; Levin et al., 1998).
In comparison, the CPT-IP instructs the participant to respond by pressing a key when two identical stimuli are presented in sequence (the target), and refrain from responding when the 2nd stimulus does not match the preceding stimulus. Thus, the participant must process and hold in working memory the first stimulus long enough to compare it to the next stimulus. As such, the CPT-IP carries a working memory load and is considered more demanding than the C-CPT. The three blocks of 150 trials are presented with increasing cognitive load, in which the first block contains two-digit targets, the second block three-digit targets, and the third block four-digit targets. In contrast to the C-CPT, the CPT-IP has a lower signal-to noise ratio (d’); target stimulus-pairs (signal) occur 20% of the time, and the non-target stimulus-pairs (noise) occur 80% of the time.
1.2. Previous Findings of Sustained Attention and Nicotine Effects in the Patient Population
The nuances between the C-CPT and CPT-IP may lead researchers to different conclusions about sustained attention deficits and the effects of nicotine on components of sustained attention in the patient population. Previous studies have looked at different combinations of smokers, nonsmokers, patients, and healthy controls when examining the effects of nicotine on sustained attention in schizophrenia.Smith et al. (2006) found that a nicotine nasal spray significantly decreased C-CPT hit reaction time in 12-hour nicotine-deprived patient smokers. Sacco et al., (2005) found nicotine reversed the effects of overnight smoking abstinence on C-CPT hit rate impairments but not reaction time in patient smokers and healthy control smokers; Levin et al., (1996) found nicotine administration significantly improved C-CPT hit reaction time standard error in 8/hr nicotine-deprived patient smokers.Hahn et al. (2012),found no differences between non-deprived patient smokers and patient nonsmokers on the CPT-IP. Wing et al., (2010), found patient nonsmokers had significantly lower hit rates on C-CPT, compared to non-deprived patient smokers and patient former-smokers. Employing the CPT-IP,Barr et al. (2008) found that nicotine administration significantly decreased hit reaction time, hit reaction time standard deviation, and errors of commission, but not hit rate in patient and control nonsmokers. Depatie et al. (2002) compared 9.5/hour nicotine deprived patient smokers to healthy control smokers and found nicotine significantly improved CPT-IP hit rate and d’.
Both Connor's CPT and CPT-IP are sensitive to nicotine or smoking, but may be different considering psychopathology. Researchers have examined the effects of nicotine on sustained attention in patients by comparing patient smokers to healthy control smokers (Depatie et al. 2002; Sacco et al., 2005) or patient nonsmokers to healthy control nonsmokers (Barr et al., 2008). Other studies have looked at only patient smokers (Smith et al., 2006; Levin et al., 1996), or patient nonsmokers (Dyer et al., 2008). Only two studies to date (to our knowledge) has looked at both patient smokers and patient nonsmokers on measures of sustained attention (Hahn et al., 2012;Wing et al., 2011). Additionally, there is no standard instrument for measuring sustained attention, with some studies employing the C-CPT (Smith et al., 2006; Sacco et al., 2005; Levin et al., 1996), and others employing the CPT-IP (Barr et al., 2008; Depatie et al., 2002; Dyer et al., 2008). To our knowledge, no studies to date have directly compared Conner's CPT vs. CPT-IP between patient smokers and patient nonsmokers.
1.3. The Present Study
The purpose of the present study was to test whether there were overall differences between patient smokers and nonsmokers on sustained attention, and if one task, the C-CPT or CPT-IP, might better capture sustained attention deficits in patient smokers and patient nonsmokers. We hypothesized that if the self-medication theory holds true, patient smokers may perform better on sustained attention tasks compared to nonsmokers. We also reasoned that the CPT-IP, which was created for measuring sustained attention with a working memory demand specifically for differentiating schizophrenia and healthy controls (Cornblatt et al., 1988), would be more sensitive and therefore more effective in distinguishing sustained attention differences compared to the C-CPT, which was developed to be sensitive to impulsivity. Because the C-CPT and CPT-IP have comparable composite measures (i.e., d’, hit rate, hit rate response time, hit rate response time standard deviation, and errors of commission) we hypothesized that the composite scores of the CPT-IP, when compared to the C-CPT, would be significantly better at distinguishing patient smokers from patient nonsmokers.
2. Material and methods
2.1. Participants
All participants (N= 53, mean age 40.58, range 19–55) were outpatients identified as having schizophrenia or schizoaffective disorder, received antipsychotic medication, and were clinically stable for 4 weeks or longer. Two patients received first generation antipsychotics; the remainder received second generation antipsychotics Participants were either current smokers (n=31), defined as smoking any amount of cigarettes every day for a year, or nonsmokers (n= 22) who had never smoked (< than 100 cigarettes smoked in lifetime) or had not smoked within the past year. Patients undergoing smoking cessation therapy were excluded, as were patients with major medical conditions, atrioventricular block identified on an electrocardiogram, and/or renal insufficiency.
2.2. Procedure
All participants gave informed consent which was approved by the University of Maryland institutional review board. Following consent, each participant completed a semi-structured interview and answered clinical and demographic information, and CO measurement was collected (not timed to the last cigarette). Participants then completed the C-CPT and CPT-IP. Patient smokers were allowed to smoke ad libitum no less than 30 minutes before each CPT testing to avoid peak nicotine level from last cigarette, but also to avoid early withdrawal symptoms from prolonged abstinence. Study duration was approximately 2-hours.
2.3. Assessments
2.3.1. Clinical
The Brief Psychiatric Rating Scale, BPRS, (Overall & Gorham, 1962) was the primary measure used to assess diagnosis related symptoms. Negative symptoms were assessed with the Schedule for Negative Symptoms, (SANS; Andreasen, 1984); patients’ overall level of functioning was assessed with the Global Assessment of Functioning Scale, (GAF; Endicott et al., 1976). The Hamilton Scale for Depression, (HAMD; Hamilton, 1960), was used to assess patients for depression.
2.3.2. Smoking Status
The number of cigarettes smoked per day (CPD) was the primary measure to establish smoking status. Smokers were considered those who indicated smoking any amount of cigarettes a day for the last year or longer. The end-expired carbon monoxide level (COLevel) was collected from smokers only as a means to approximate validation of the CPD measure. Patient smokers were allowed to smoke if desired no less than 30 minutes before each CPT testing. The 1 hr to 30 minute smoking window was to avoid peak nicotine level from last cigarette, but also to avoid early withdrawal sx from prolonged abstinence
2.3.3. Neuropsychological
Sustained attention was assessed with both the C-CPT and CPT-IP. Composite measures included: discriminative power (d'): the difference between the signal and noise distributions, a higher number indicates a better ability to detect the signal from noise; hit rate: the amount of correct signal detections; hit reaction time: milliseconds to have correct response; hit reaction time standard deviation; the average variation in hit reaction time; commission errors: errors made to non-targets, a measure of impulsivity; and omission errors: individual's response tendency to avoid errors of commission
2.4. Statistical Analysis
One-way analysis of variance (ANOVA) was used to assess the differences between smokers and nonsmokers. Alpha was established at 0.05. The CPT-IP was analyzed in two ways: 1) as a composite of the three blocks of 150 trials; and 2) using only the third, and most difficult block (CPT-IP-3). Cohen’s effect size (d) were computed for all t-tests and evaluated with suggested norms for effect size: small = 0.20; medium = 0.50; large = 0.80, The Spearman rank correlation was limited to composite scores that showed significant smoking status effects.
3. Results
3.1. Demographic and Clinical Variables
The two groups were similar in terms of sex and age (p= .770) (Table 1). There were no differences in BPRS total symptom score (p= .968) negative symptoms (p= .205), nor depression (p= .363) between the schizophrenia smokers and schizophrenia nonsmokers. Smoking related measures are shown in Table 1. The average number of cigarettes smoked per day (CPD) of the smokers was 17 (SD=13.11; Range= 1–40), and their average end-expired carbon monoxide level (COLevel) was 17.58 (SD= 10.70; Range= 0–37).
Table 1.
Descriptives and Results of Clinical Baseline Measures
| Measure | Non-smoking N= 22 Mean (sd) |
Smoking N= 31 Mean (sd) |
F | Sig |
|---|---|---|---|---|
| Gender (% male) | 14 males (64%) | 22 males (71%) | X2 = .03 | .874 |
| Age | 41.09 (9.71) | 40.23 (11.13) | .09 | .770 |
| CPDa | - | 17.00 (13.11) | - | - |
| CoLevel | - | 17.58 (10.70) | - | - |
| SANSb | 20.23 (9.50) | 24.48 (13.30) | 1.65 | .205 |
| GAFc | 49.77(10.01) | 47.58 (9.74) | .63 | .430 |
| BPRSd | 57.17 (27.80) | 47.44 (21.07) | .02 | .968 |
| HAMDe | 6.05 (3.82) | 5.10(3.62) | .84 | .363 |
CPD= Cigarettes per Day
SANS= Schedule for Negative Symptoms
GAF= Global Assessment of Functioning Scale
BPRS= The Brief Psychiatric Rating Scale
HAMD= The Hamilton Scale for Depression
3.2. Neuropsychological Performance
Neuropsychological task performance was compared between schizophrenic smokers (n=31) and schizophrenic nonsmokers (n= 22), (Table 2). The data were analyzed using one-way ANOVAs for smoking status. Inspection of Table 2 indicates that patients perform similarly on the CPT-IP as averaged across blocks and on the third block only. As such, the third block of the CPT-IP is considered as the primary measure of sustained attention on the CPT-IP.
Table 2.
Descriptives and ANOVA Results of Patient Smokers vs. Patient Nonsmokers on the C-CPTa, CPT-IPb, and CPT-IP 3c
| Measure | Non-smoking Mean (sd) |
Smoking Mean (sd) |
F | p-value | d | |
|---|---|---|---|---|---|---|
| d’ | ||||||
| C-CPT | 1.02 (.44) | .82 (.46) | 2.54 | .117 | .501 | |
| CPT-IP | 2.39 (.74) | 1.89 (1.01) | 3.97 | .052 | .677 | |
| CPT-IP 3 | 1.53 (.81) | .93 (.76) | 7.63 | .008 | .817 | |
| Hit Rate | ||||||
| C-CPT | 312.50 (15.64) 97% | 307.35 (22.78) 95% | .84 | .364 | .670 | |
| CPT-IP | 24.21 (4.89) 81% | 20.75 (6.32) 69% | 4.62 | .036 | .790 | |
| CPT-IP 3 | 22.36 (5.70) 75% | 17.61 (6.43) 59% | 7.71 | .008 | .966 | |
| Hit Response Time | ||||||
| C-CPT | 435.98 (119.75) | 463.53 (113.68) | .72 | .399 | .168 | |
| CPT-IP | 535.11 (64.55) | 547.73 (96.43) | .29 | .596 | .238 | |
| CPT-IP 3 | 541.58 (78.85) | 554.21 (111.35) | .21 | .650 | .000 | |
| Hit Response Time SD | ||||||
| C-CPT | 9.11 (4.72) | 12.19 (7.74) | 2.74 | .104 | .403 | |
| CPT-IP | 129.52 (26.99) | 164.20 (48.30) | 9.25 | .004 | .725 | |
| CPT-IP 3 | 127.78 (35.76) | 171.37 (69.07) | 7.34 | .009 | .094 | |
| Commission Errors | ||||||
| C-CPT | 8.91 (5.14) | 12.77 (6.89) | 4.96 | .030 | .089 | |
| CPT-IP | 4.09 (2.71) | 4.80 (3.83) | .55 | .462 | .006 | |
| CPT-IP 3 | 8.05 (5.18) | 8.29 (5.76) | .032 | .860 | .001 | |
| Response Style/ Randoms | ||||||
| C-CPT | 1.46 (1.52) | 1.04 (1.14) | 1.29 | .261 | .033 | |
| CPT-IP | 1.56 (2.07) | 4.59 (4.58) | 8.37 | .006 | .126 | |
| CPT-IP 3 | 2.14 (3.71) | 6.74 (8.08) | 6.20 | .016 | .093 |
Bolded items indicate significant differences between patient smokers and patient nonsmokers.
C-CPT= Conners’ Continuous Performance Task
CPT-IP= Continuous Performance Task- Identical Pairs
CPT-IP 3= Third, and most difficult, block of the Continuous Performance Task- Identical Pairs
Performance was significantly impaired in schizophrenia smokers on the majority of the CPT-IP-3 composite scores compared to schizophrenia nonsmokers. Of the six composite measures, four were significant with large or medium effect sizes: d’ (F(1,52)= 7.63, p < .01, η2 = .14), Hit Rate (F(1,52)= 7.71, p < .01, η2 = .19), Hit Rate Reaction Time Standard Deviation (F(1,52)= 8.35, p < .01, η2 = .09) and Random Errors (F(1,52)= 6.20, p < .05, η2 = .09). CPT-IP composite scores that failed to reach significance included: False Alarms (F(1,52)= .032, p > .05), and Response Time (F(1,52)= .21, p > .05).
For C-CPT, only one of the six composite scores was significantly different between the two groups. Commission errors, the tendency for a participant to respond incorrectly, was significantly more common in schizophrenia smokers compared to schizophrenia nonsmokers, and showed a medium effect size (F(1, 52)= 4.96, p= .030, η2 = .09). The remaining C-CPT composite measures failed to reach significance: d’ (F(1, 52)= 2.54, p= .117), Hit Rate (F(1, 52)= .84, p= .364), Hit Response Time (F(1, 52)= .72, p= .40), and Response Time SD (F(1, 52)= 1.29, p= .261).
4. Discussion
Our comparative study of two sustained attention assessment instruments, the C-CPT and the CPT-IP, revealed that both tasks detect more impaired sustained attention in patient smokers compared to nonsmokers, although the CPT-IP was more sensitive for detecting group differences in sustained attention in this context. The CPT-IP features a progressive cognitive load across blocks which taxes working memory, where the C-CPT maintains the same difficulty level throughout blocks and does not tax working memory. However, these between task nuances do not explain the underlying mechanisms contributing to group differences between patient smokers and nonsmokers. For example,Hahn et al. (2012), did not find differences between patient smokers and nonsmokers on the CPT-IP, however, the majority (83%) of participants were inpatient. As such, there may also be differences between inpatient and outpatient status of nicotine effects on sustained attention. Clinical and demographic measures did not differ between the two groups, so our findings are not due to significant differences in these measures between the two groups. We also correlated COLevel before cognitive testing and the sustained attention measures that showed significantly differences between smokers and nonsmokers, and found COLevel was not significantly correlated with any of the sustained attention composite scores. These findings suggest that the worsened sustained attention in smokers is not related to the recency of smoking. Our finding of more severe deficits of sustained attention in patient smokers does not support the self-medication theory, at least at its face value. The self-medication theory would predict that smokers to have improved sustained attention, because these smokers are not smoking-deprived (COLevel = 17). However, patient smokers may have worse sustained attention even before they become smokers, a possibility our study was not designed to refute or support.
The interpretation of the results in the current study is constrained by several limitations. First, patients who indicated smoking any amount of cigarettes every day for at least a year were considered smokers. As such, the range of cigarettes smoked per day ranged from 1 to 40. There may be differences of sustained attention when assessed on a light to heavy smoking continuum. Additionally, former smokers were entered as nonsmokers. It may be that former patient smokers behave more like patient smokers on measures of sustained attention; however, our design did not distinguish between former and never smokers. Additionally, we did not ask nor record the timing of the last cigarette smoked by patient smokers. Patient smokers were allowed to smoke ad libitum no sooner than 30 minutes before each CPT testing. Thus, to further control for smoking recency effects, it may have been beneficial to record COLevels before each CPT testing as well as upon arrival. Demographic information such as education level was not collected, and it may have been to correlate education status with performance on the attentional levels. Lastly, statistical interpretation may be compromised by the increased risk of making a Type 1 error due to performing 18 one-way ANOVAs as we did not correct for multiple comparisons.
In summary, there has been a considerable amount of study dedicated to understanding the neuropsychological functioning of the schizophrenic population (Hong et al., 2011; Barr et al., 2008). There may be pre-existing differences in nAChR between patient smokers and nonsmokers that account for differences in neuropsychological functioning. To our knowledge, this is the first direct evidence that sustained attention deficits may be more impaired in outpatient smokers compared to outpatient nonsmokers. The present study is also the first to concurrently compare the ability of the C-CPT to the CPT-IP to distinguish between smokers and nonsmokers with schizophrenia. Our results suggest that the CPT-IP is a more sensitive tool for this purpose. These differences may be important for researchers studying neuropsychological functioning in schizophrenia when selecting assessment instruments. Controlling for smoking status may also be warranted.
Table 3.
| CPD | d’ CPT-IP 3 | Hit Rate CPT- IP 3 |
Hit Rate SD CPT-IP 3 |
Commission Errors C-CPT |
Random Errors CPT-IP 3 |
|
|---|---|---|---|---|---|---|
| COLevel (n=31) |
r= .61 p= .000 |
r= −.13 p= .477 |
r= .19 p= .494 |
r= .14 p= .444 |
r= −.00 p= .996 |
r= =.29 p= .112 |
| d’ CPT-IP 3 |
- |
r= .70 p= .000 |
r= −.31 p= .024 |
r= −.30 p= .031 |
r= =.54 p= .000 |
|
| Hit Rate CPT-IP 3 |
- |
r= −.39 p= .004 |
r= −.25 p= .075 |
r= −.37 p= .007 |
||
| Hit Rate SD CPT- IP 3 |
r= .24 p= .088 |
r= .59 p= .000 |
||||
| Commission Errors C-CPT |
r= .24 p= .084 |
Bolded items reflect significant correlations
CPD= Cigarettes per Day.
C-CPT= Conners’ Continuous Performance Task
CPT-IP 3= Third, and most difficult, block of the Continuous Performance Task- Identical Pairs
Acknowledgements
We kindly thank Kaitlyn Kavanagh and Katherine Lesniak for their assistance with data entry.
Role of Funding Source
This work was supported by the Stanley Medical Research Institute (grant 06TAF-966), the National Institutes of Health (grants DA027680, MH085646, and MH077852), and the Neurophysiology Core of the University of Maryland General Clinical Research Center (grant M01-RR16500).
Footnotes
Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.
Conflict of Interest
There are no conflicts of interest to report for any of the authors.
Contributors
Michelle Roth conducted statistical analysis, interpreted results, and wrote the manuscript. L. Elliott Hong designed the study, wrote the protocol, and assisted with manuscript preparation. Robert P. McMahon provided oversight for statistical analyses and assisted in manuscript preparation. Rebecca L. Fuller assisted with methodology, interpreting the results and manuscript preparation. All authors contributed to and have approved the final manuscript.
References
- Andreasen NC. Scale for the assessment of negative symptoms SANS. Iowa City: University of Iowa; 1984. [Google Scholar]
- Barkley RA, Murphy K, Kwasnik D. Psychological adjustment and adaptive impairments in young adults with ADHD. J. of Attent Dis. 1996;1:41–54. [Google Scholar]
- Barr RS, Culhane MA, Jubelt LE, Mufti RS, Dyer MA, Weiss AP, Deckersbach T, Kelly JF, Freudenreich O, Goff DC, Evins AE. The effects of transdermal nicotine on cognition in nonsmokers with schizophrenia and nonpsychiatric controls. Neuropsychopharmacology. 2008;333:480–490. doi: 10.1038/sj.npp.1301423. [DOI] [PubMed] [Google Scholar]
- Conners CK. Technical guide and software manual. North Tonawanda, NY: Multi Health Systems; 2002. Conners’ continuous performance test CPT-II. [Google Scholar]
- Cornblatt BA, Risch NJ, Faris G, Friedman D, Erlenmeyer-Kimling L. The continuous performance test, identical pairs version CPT-IP: I. New findings about sustained attention in normal families. Psychiatry Res. 1988;26:223–238. doi: 10.1016/0165-1781(88)90076-5. [DOI] [PubMed] [Google Scholar]
- D’Souza MS, Markou A. Schizophrenia and tobacco smoking comorbidity: nAChR agonists in the treatment of schizophrenia-associated cognitive deficits. Neuropharmacology. 2012;623:1564–1573. doi: 10.1016/j.neuropharm.2011.01.044. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Dépatie L, O'Driscoll GA, Holahan AV, Atkinson V, Thavundayil JX, Kin NN, Lal S. Nicotine and behavioral markers of risk for schizophrenia: A double-blind, placebo-controlled, cross-over study. Neuropsychopharmacology. 2002;276:1056. doi: 10.1016/S0893-133X(02)00372-X. [DOI] [PubMed] [Google Scholar]
- Dyer MA, Freudenreich O, Culhane MA, Pachas GN, Deckersbach T, Murphy E, Goff DC, Evins AE. High-dose galantamine augmentation inferior to placebo on attention, inhibitory control and working memory performance in nonsmokers with schizophrenia. Schizophr. Res. 2008;102(1–3):88–95. doi: 10.1016/j.schres.2007.12.491. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Endicott J, Spitzer RL, Fleiss JL, Cohen J. The global assessment scale. A procedure for measuring overall severity of psychiatric disturbance. Arch. Gen. Psychiatry. 1976;33:766–771. doi: 10.1001/archpsyc.1976.01770060086012. [DOI] [PubMed] [Google Scholar]
- Hamilton M. A rating scale for depressionJNeurol. Neurosurg. Psychiatry. 1960;23:56–62. doi: 10.1136/jnnp.23.1.56. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hahn C, Hahn E, Dettling M, Güntürkün O, Tam Ta T, Neuhaus AH. Effects of smoking history on selective attention in schizophrenia. Neuropharmacology. 2012;624:1897–1902. doi: 10.1016/j.neuropharm.2011.12.032. [DOI] [PubMed] [Google Scholar]
- Hong LE, Thaker GK, McMahon RP, Summerfelt A, Rachbeisel J, Fuller RL, Wonodi I, Buchanan RW, Myers C, Heishman SJ, Yang J, Nye A. Effects of moderate-dose treatment with varenicline on neurobiological and cognitive biomarkers in smokers and nonsmokers with schizophrenia or schizoaffective disorder. Arch. Gen. Psychiatry. 2011;6812:1195–1206. doi: 10.1001/archgenpsychiatry.2011.83. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Levin ED, Wilson W, Rose JE, McEvoy J. Nicotine-haloperidol interactions and cognitive performance in schizophrenics. Neuropsychopharmacology. 1996;15:429–436. doi: 10.1016/S0893-133X(96)00018-8. [DOI] [PubMed] [Google Scholar]
- Levin ED, Conners C, Silva D, Hinton SC, Meck WH, March J, Rose JE. Transdermal nicotine effects on attention. Psychopharmacology. 1998;1402:135. doi: 10.1007/s002130050750. [DOI] [PubMed] [Google Scholar]
- Overall JE, Gorham DR. The Brief Psychiatric Rating Scale. Psychol. Rep. 1962;10:799–812. [Google Scholar]
- Sacco KA, Termine A, Seyal A, Dudas MM, Vessicchio JC, Krishnan-Sarin S. Effects of cigarette smoking on spatial working memory and attentional deficits in schizophrenia: involvement of nicotinic receptor mechanisms. Arch. Gen. Psychiatry. 2005;62:649–659. doi: 10.1001/archpsyc.62.6.649. [DOI] [PubMed] [Google Scholar]
- Segarra R, Zabala A, Eguíluz J, Ojeda N, Elizagarate E, Sánchez P, Ballesteros J, Gutiérrez M. Cognitive performance and smoking in first-episode psychosis: the self-medication hypothesis. Eur. Arch. Psychiatry Neurol. Sci. 2011;261(4):241–250. doi: 10.1007/s00406-010-0146-6. [DOI] [PubMed] [Google Scholar]
- Smith RC, Warner-Cohen J, Matute M, Butler E, Kelly E, Vaidhyanathaswamy S, Khan A. Effects of nicotine nasal spray on cognitive function in schizophrenia. Neuropsychopharmacology. 2006;31(3):637–643. doi: 10.1038/sj.npp.1300881. [DOI] [PubMed] [Google Scholar]
- Wing VC, Bacher I, Sacco KA, George TP. Neuropsychological performance in patients with schizophrenia and controls as a function of cigarette smoking status. Psychiatry Res. 2011;188(3):320–326. doi: 10.1016/j.psychres.2011.05.037. [DOI] [PMC free article] [PubMed] [Google Scholar]
